nach oben

Familial Cancer

Erschienen in:

01.12.2010

Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives

verfasst von: Afsaneh Hayat Roshanai, Claudia Lampic, Richard Rosenquist, Karin Nordin

Erschienen in: Familial Cancer | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the present descriptive study was to investigate the experience of sharing genetic information among cancer genetic counselees and their at-risk relatives.

Methods

In total, 147 cancer genetic counselees and 81 of their at-risk relatives answered to a study specific questionnaire and/or were interviewed. Counselees’ communication of genetic information to at-risk relatives was assessed with regard to who they informed, how they felt, and how they perceived their relatives’ reactions. In addition, at-risk relatives’ experiences of receiving genetic information were studied.

Results

Most of the counselees had shared the genetic information received at the counseling session personally with their at-risk relatives. The majority of the counselees (68%) reported positive or neutral feelings about sharing the genetic information with their relatives while 9% stated negative feelings. Counselees mostly interpreted the relatives’ reactions to the information as positive or neutral (62% of responses), and in few cases as negative (14% of responses). About half of relatives reported positive or neutral reactions (54%) to the received information, while about one-fifth reported negative reactions (22%). Nevertheless, most relatives were satisfied with the received information and half of the relatives intended to seek genetic counseling themselves.

Conclusion

Sharing genetic information to at-risk relatives appears to be accomplished without any major difficulties or negative feelings. However, more assistance may be needed to optimize the communication of the genetic information within at-risk families.

Nur mit Berechtigung zugänglich

From now on referred to as relatives in the intervention or relatives in the control group.

Miesfeldt S, Cohn WF, Jones SM, Ropka ME, Weinstein JC (2003) Breast cancer survivors’ attitudes about communication of breast cancer risk to their children. Am J Med Genet C Semin Med Genet 119C(1):45–50CrossRefPubMed

Forrest LE, Delatycki MB, Skene L, Aitken M (2007) Communicating genetic information in families—a review of guidelines and position papers. Eur J Hum Genet 15(6):612–618CrossRefPubMed

Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E (2003) Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 116A(1):11–19CrossRefPubMed

Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M (2003) Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics 29(2):74–79 discussion 80-3CrossRefPubMed

d’Agincourt-Canning L (2001) Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 15(3):231–247CrossRefPubMed

Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N et al (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64(4):317–326CrossRefPubMed

Cypowyj C, Eisinger F, Huiart L, Sobol H, Morin M, Julian-Reynier C (2009) Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives. Psychooncology 18(2):209–215CrossRefPubMed

Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M (2002) Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 6(2):79–87CrossRefPubMed

Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S et al (2002) All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 107(2):143–150CrossRefPubMed

10.

Hamilton RJ, Bowers BJ, Williams JK (2005) Disclosing genetic test results to family members. J Nurs Scholarsh 37(1):18–24CrossRefPubMed

11.

Smith KR, Zick CD, Mayer RN, Botkin JR (2002) Voluntary disclosure of BRCA1 mutation test results. Genet Test 6(2):89–92CrossRefPubMed

12.

Gallo AM, Angst DB, Knafl KA (2009) Disclosure of genetic information within families. Am J Nurs 109(4):65–69PubMed

13.

Douglas HA, Hamilton RJ, Grubs RE (2009) The effect of BRCA gene testing on family relationships: a thematic analysis of qualitative interviews. J Genet Couns 18(5):418–435CrossRefPubMed

14.

Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C et al (2005) Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet 67(6):492–502CrossRefPubMed

15.

Adelswäard V, Sachs L (2003) The messenger’s dilemmas—giving and getting information in genealogical mapping for hereditary cancer. Health Risk Soc 5(2):125–138CrossRef

16.

Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE (2006) Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 24(4):700–706CrossRefPubMed

17.

Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B et al (2004) The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 41(3):e23CrossRefPubMed

18.

Roshanai AH, Rosenquist R, Lampic C, Nordin K (2009) Does enhanced information at cancer genetic counseling improve counselees’ knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives? A randomized study. Acta Oncol 27:1–11

19.

Buckman R (1992) How to break bad news: a guide for health care professionals. Johns Hopkins Universty Press, Baltimore

20.

Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK et al (2003) How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 119C(1):78–86CrossRefPubMed

21.

Bonadona V, Saltel P, Desseigne F, Mignotte H, Saurin JC, Wang Q et al (2002) Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers Prev 11(1):97–104PubMed

22.

Weber R (1990) Basic content analysis. Sage publications, London

23.

MacDonald DJ, Sarna L, van Servellen G, Bastani R, Giger JN, Weitzel JN (2007) Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genet Med 9(5):275–282CrossRefPubMed

24.

Bjorvatn C, Eide GE, Hanestad BR, Oyen N, Havik OE, Carlsson A et al (2007) Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. J Genet Couns 16(2):211–222CrossRefPubMed

Titel: Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives
verfasst von: Afsaneh Hayat Roshanai
Claudia Lampic
Richard Rosenquist
Karin Nordin
Publikationsdatum: 01.12.2010
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 4/2010
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-010-9364-3

Springer Medizin

Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits

Communicating genetic risk information within families: a review

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study

MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions

Thymoma associated with malignancies may herald a hereditary cancer syndrome

Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie